CLINICAL_TRIALS
research
· 2014-09-30
Clinical Trial Update: Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment. [Phase 3]
Summary
This entry reports a Phase 3 clinical trial evaluating sentinel lymph node biopsy with superparamagnetic iron oxide for breast cancer patients after neoadjuvant…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN